Last Updated: May 12, 2026

Suppliers and packagers for levocarnitine


✉ Email this page to a colleague

« Back to Dashboard


levocarnitine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Am Regent LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075861 ANDA American Regent, Inc. 0517-1045-05 5 VIAL, SINGLE-DOSE in 1 CARTON (0517-1045-05) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-1045-01) 2023-06-21
Am Regent LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075861 ANDA American Regent, Inc. 0517-1075-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0517-1075-01) / 20 mL in 1 VIAL, SINGLE-DOSE 2023-06-21
Deva Holding As LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 217430 ANDA Devatis Inc. 73043-034-05 5 VIAL in 1 CARTON (73043-034-05) / 5 mL in 1 VIAL 2025-11-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Levocarnitine: Supplier Landscape and Procurement-Ready Shortlist

Last updated: April 25, 2026

Who supplies levocarnitine at commercial scale?

Levocarnitine is supplied by a mix of ingredient specialists, bulk chemical producers, and branded API makers. The most procurement-relevant suppliers are the ones that publish manufacturing footprints (sites/countries), supply compliance documentation (GMP, DMF/CEP where applicable), and sell in API or intermediate form (bulk levocarnitine base, levocarnitine HCl, or related salt variants).

Below is a supplier shortlist structured for commercial sourcing and due diligence.

Procurement-ready supplier categories

Category Typical offering How procurement evaluates fit
API producers (levocarnitine base / HCl) Bulk API and/or grades for pharmaceutical formulation GMP status, ability to support DMF/CEP, CoA and stability packages
Multi-purpose chemical distributors Branded bulk or relabeled API Traceability, change control, source-of-supply transparency
Contract manufacturers (custom salts / particle control) Specific salt forms, custom specs Batch record access, analytics, and regulatory support

Which specific suppliers sell levocarnitine (API and salts)?

The following companies are established suppliers in the levocarnitine value chain and are consistently referenced in global commerce listings and/or supplier catalogs for pharmaceutical-grade levocarnitine and related salts.

Supplier shortlist (global)

Supplier Common product forms seen in market Typical customer fit
Sigma-Aldrich / Merck Levocarnitine and levocarnitine-related standards/salts (varies by SKU) Research and pilot procurement; traceability via established catalog channel
TCI Chemicals Levocarnitine and derivatives (catalog availability varies) Lab-to-pilot purchases; not always regulated API supply
Cayman Chemical Levocarnitine (research-use catalog) Screening and lab scale
Alfa Aesar (Thermo Fisher Scientific) Levocarnitine (catalog availability varies) Lab and intermediate scale
CordenPharma (via chemical development and manufacturing ecosystem) Carnitine-related intermediates and GMP services (site-dependent) GMP outsource pathway where contract manufacturing is used

Supplier shortlist (ingredient manufacturers and API-oriented firms)

Supplier Market role What to confirm in procurement
Lonza Large-scale API and chemical manufacturing ecosystem Whether the specific levocarnitine grade is offered as a finished API versus a service
Fujifilm Wako Chemical supplier with pharmaceutical-adjacent sourcing Whether product is API-grade with regulatory support
Zhejiang NHU / related CN suppliers (China-based ingredient makers) Bulk ingredient manufacturing GMP status, DMF/CEP support, and import documentation

Which suppliers are most relevant for pharmaceutical-grade procurement (vs research-grade)?

For pharmaceutical manufacturing inputs, procurement usually restricts the approved vendor universe to suppliers that can support at least one of the following:

  • GMP manufacturing at a named site
  • Regulatory dossier support (DMF for US filings, CEP for EU)
  • Batch release documentation (CoA, analytics, stability protocol)

In practical procurement terms:

  • Catalog suppliers (research-grade heavy) can be acceptable for development but typically do not meet commercial API dossier and audit requirements.
  • API-focused or dossier-supporting manufacturers are preferred for commercial supply continuity.

How to structure an RFP for levocarnitine suppliers

The fastest path to supplier qualification is to RFP against a fixed specification and compliance package. Use a two-step request: (1) technical and regulatory snapshot, (2) quality and supply proof.

Technical package to require

  • Salt form: levocarnitine base vs levocarnitine hydrochloride (levocarnitine HCl)
  • Assay and impurity profile: define acceptance limits by your internal spec
  • Particle and polymorph controls (if relevant for formulation performance)
  • Stability data: forced degradation approach and shelf-life support

Regulatory and quality package to require

  • GMP certificate for the manufacturing site(s)
  • DMF or CEP status (where required for your filings)
  • Quality agreement readiness and audit access
  • Change control policy and notification timeline
  • CoA template and batch traceability approach

Market procurement notes that affect supplier selection

Salt form drives supplier match

Levocarnitine is sold in different chemical forms, and procurement should not assume cross-compatibility:

  • Levocarnitine base vs levocarnitine HCl can change:
    • intake strength per gram,
    • dissolution behavior,
    • impurity burden.

Supplier responsiveness depends on grade stratification

Many suppliers carry both:

  • research-grade bulk (fast lead times, minimal regulatory paperwork), and
  • pharmaceutical-grade API (slower lead times, formal QMS, dossier linkage).

Qualification gates should be set to avoid mismatches.

Supplier due-diligence checklist (audit points)

Procurement teams typically confirm:

  • manufacturing route and control strategy,
  • solvent and catalyst residual controls,
  • impurity identification method and update policy,
  • endotoxin/bioburden position if your use case touches sterile processing,
  • incoming material controls for intermediates (if levocarnitine is produced via intermediates).

Key Takeaways

  • Levocarnitine sourcing spans research-grade catalog suppliers and API-focused manufacturers; pharmaceutical procurement should weight vendors that can supply GMP + dossier support.
  • Salt form (base vs levocarnitine HCl) is a primary supplier fit discriminator and can affect dose-equivalence, impurity profile, and formulation behavior.
  • A procurement-ready RFP should lock technical specs first, then demand dossier-grade documentation, CoA templates, change control, and audit access.

FAQs

  1. Is levocarnitine typically sourced as the base or as levocarnitine HCl?
    Both are used in the market; which one you should buy depends on your formulation strength calculations and regulatory spec for your product.

  2. Which suppliers are best for commercial API supply vs lab-grade purchasing?
    Commercial supply usually requires GMP and dossier support; many catalog chemical suppliers are optimized for research-grade orders.

  3. What documents matter most when qualifying a levocarnitine supplier?
    GMP certificate, CoA/analytics package, and dossier support (DMF/CEP where needed), plus change control and audit access.

  4. Does impurity profiling differ materially across suppliers?
    Yes. Impurity control depends on the synthetic route, raw material controls, and purification steps, so acceptance limits should be vendor-qualified.

  5. What is the fastest way to reduce supplier qualification cycles?
    Issue an RFP with locked specification targets and require dossier-grade documentation up front, then run documentation review in parallel with an on-site audit request.


References

[1] Merck. Levocarnitine (products and product documentation). Sigma-Aldrich/Merck catalog.
[2] TCI Chemicals. Levocarnitine (product listings and specifications). TCI catalog.
[3] Cayman Chemical. Levocarnitine (product listing). Cayman Chemical catalog.
[4] Thermo Fisher Scientific. Alfa Aesar levocarnitine (product listing). Alfa Aesar/Thermo Fisher catalog.
[5] Lonza. GMP manufacturing and API/chemical services overview (site-dependent offerings). Lonza corporate information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.